GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Universe Pharmaceuticals Inc (NAS:UPC) » Definitions » Gross Margin %

Universe Pharmaceuticals (Universe Pharmaceuticals) Gross Margin % : 30.25% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Universe Pharmaceuticals Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Universe Pharmaceuticals's Gross Profit for the six months ended in Sep. 2023 was $4.19 Mil. Universe Pharmaceuticals's Revenue for the six months ended in Sep. 2023 was $13.84 Mil. Therefore, Universe Pharmaceuticals's Gross Margin % for the quarter that ended in Sep. 2023 was 30.25%.

Warning Sign:

Universe Pharmaceuticals Inc gross margin has been in long-term decline. The average rate of decline per year is -2.5%.


The historical rank and industry rank for Universe Pharmaceuticals's Gross Margin % or its related term are showing as below:

UPC' s Gross Margin % Range Over the Past 10 Years
Min: 31.93   Med: 46.47   Max: 54.53
Current: 31.93


During the past 6 years, the highest Gross Margin % of Universe Pharmaceuticals was 54.53%. The lowest was 31.93%. And the median was 46.47%.

UPC's Gross Margin % is ranked worse than
74.54% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.51 vs UPC: 31.93

Universe Pharmaceuticals had a gross margin of 30.25% for the quarter that ended in Sep. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Universe Pharmaceuticals was -2.50% per year.


Universe Pharmaceuticals Gross Margin % Historical Data

The historical data trend for Universe Pharmaceuticals's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universe Pharmaceuticals Gross Margin % Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Gross Margin %
Get a 7-Day Free Trial 40.35 45.90 52.78 54.53 31.93

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 56.30 56.84 51.03 33.18 30.25

Competitive Comparison of Universe Pharmaceuticals's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Universe Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universe Pharmaceuticals's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Universe Pharmaceuticals's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Universe Pharmaceuticals's Gross Margin % falls into.



Universe Pharmaceuticals Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Universe Pharmaceuticals's Gross Margin for the fiscal year that ended in Sep. 2023 is calculated as

Gross Margin % (A: Sep. 2023 )=Gross Profit (A: Sep. 2023 ) / Revenue (A: Sep. 2023 )
=10.3 / 32.309
=(Revenue - Cost of Goods Sold) / Revenue
=(32.309 - 21.994) / 32.309
=31.93 %

Universe Pharmaceuticals's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=4.2 / 13.842
=(Revenue - Cost of Goods Sold) / Revenue
=(13.842 - 9.655) / 13.842
=30.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Universe Pharmaceuticals  (NAS:UPC) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Universe Pharmaceuticals had a gross margin of 30.25% for the quarter that ended in Sep. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Universe Pharmaceuticals Gross Margin % Related Terms

Thank you for viewing the detailed overview of Universe Pharmaceuticals's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universe Pharmaceuticals (Universe Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
265 Jingjiu Avenue, Economic & Technological Development Zone, Jinggangshan, Jiangxi, Ji’an, CHN
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Universe Pharmaceuticals (Universe Pharmaceuticals) Headlines

From GuruFocus